BETA


2022/0216(COD) Standards of quality and safety for substances of human origin intended for human application

Progress: Procedure completed, awaiting publication in Official Journal

RoleCommitteeRapporteurShadows
Lead ENVI COLIN-OESTERLÉ Nathalie (icon: EPP EPP) GONZÁLEZ CASARES Nicolás (icon: S&D S&D), GLÜCK Andreas (icon: Renew Renew), METZ Tilly (icon: Verts/ALE Verts/ALE), KOPCIŃSKA Joanna (icon: ECR ECR), KONEČNÁ Kateřina (icon: GUE/NGL GUE/NGL)
Lead committee dossier:
Legal Basis:
TFEU 168-p4

Events

2024/06/13
   CSL - Draft final act
Documents
2024/06/13
   CSL - Final act signed
2024/05/27
   EP/CSL - Act adopted by Council after Parliament's 1st reading
2024/04/24
   EP - Decision by Parliament, 1st reading
Details

The European Parliament adopted by 461 votes to 56, with 66 abstentions, a legislative resolution on the proposal for a regulation of the European Parliament and of the Council on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC.

The European Parliament’s position adopted at first reading under the ordinary legislative procedure amends the proposal as follows:

Subject matter and scope

This Regulation establishes measures that set high standards of quality and safety for all substances of human origin (SoHO) intended for human application and for activities related to those substances. It ensures a high level of human health protection, in particular for SoHO donors, SoHO recipients and offspring from medically assisted reproduction, including by strengthening the continuity of supply of critical SoHO.

The Regulation applies to: (i) SoHO intended for human application; (ii) SoHO donors, SoHO recipients and offspring from medically assisted reproduction; (iii) SoHO activities that have a direct impact on the quality, safety or effectiveness of SoHO.

It should not apply to: (i) organs intended for transplantation; (ii) breast milk when used exclusively for feeding one’s own child, without any processing carried out by a SoHO entity.

Competent authorities

Member States should designate the SoHO competent authorities to which they entrust responsibility for SoHO monitoring activities. The designated SoHO Competent Authorities should be independent from any SoHO entity. Member States should ensure that the SoHO competent authorities have sufficient human and financial resources, operational capacity and expertise, including technical expertise, to achieve the objectives of this Regulation.

When carrying out their tasks and exercising their powers, the SoHO competent authorities should act independently and impartially , in the public interest and free from any external influence, which could constitute political influence or interference by industry. They should carry out the SoHO supervisory activities for which they have been charged in a transparent manner and should make available and clear to the public any enforceable decision and the reasons for that decision, in cases where an SoHO entity fails to comply with this Regulation.

SoHO donor and recipient protection

SoHO entities should : (i) ensure respect for the dignity and integrity of SoHO donors ; (ii) ensure high levels of safety and protect the health of living SoHO donors from risks related to the SoHO donation, by identifying and minimising such risks before, during and after the SoHO collection.

Where SoHO is collected from a SoHO donor, SoHO entities should:

- provide SoHO donors or, where applicable, any person giving consent on their behalf with: (i) information in a manner appropriate to their ability to understand; (ii) the contact details of the SoHO entity responsible for the collection, from which they may, where appropriate, request further information;

- safeguard the living SoHO donor's rights to physical and mental integrity, non-discrimination, privacy and the protection of personal data;

- verify the eligibility of the living SoHO donor on the basis of an assessment of his or her state of health aimed at identifying, with a view to minimising, the risk that SoHO donation could represent for his or her health;

- check that living donors do not donate more frequently than is indicated as safe;

- draw up a plan for monitoring the donor's health after SoHO donation in cases where the donation of a substance of human origin involves a significant risk for a living donor.

SoHO entities that collect SoHO from living SoHO donors should register such SoHO donors in a SoHO entity registry or, where available, in national or recognised international registries, to verify donation frequency.

Where Member States allow for the compensation of living SoHO donors , in accordance with the principle of voluntary and unpaid donation and based on transparent criteria, including through fixed allowances, or through non-financial forms of compensation, the conditions for such compensation should be established in national legislation, including by setting an upper limit for compensation that should endeavour to guarantee financial neutrality. Any promotion and publicity activities in support of the donation of SoHO should not refer to compensation.

SoHO entities should provide living SoHO donors or, where applicable, any person giving consent on behalf of a SoHO donor, with all appropriate information relating to the SoHO donation process. This information should cover the purpose and nature of the SoHO donation, the intended use of the donated SoHO, specifically covering proven benefits for the future SoHO recipients and any possible research or commercial uses of SoHO, and the obligation for consent, in accordance with national legislation, in order for SoHO collection to be carried out.

SoHO entities should protect the health of SoHO recipients and offspring from medically assisted reproduction from risks posed by SoHO and their human application, within the scope of their competences. They should do so by identifying and minimising or eliminating those risks. Procedures that achieve high levels of quality and safety of SoHO should be established to ensure that benefits for SoHO recipients and offspring from medically assisted reproduction outweigh residual risks.

Critical SoHO supply sufficiency

Member States should, within their territories and in collaboration with SoHO national authorities, SoHO competent authorities and SoHO entities, each within their respective competence, consider all reasonable efforts for achieving a sufficient, adequate and resilient supply of critical SoHO with a view to appropriately meet recipients’ needs, and to contribute to European self-sufficiency .

Member States, in collaboration with SoHO national authorities, should draw up national SoHO emergency plans setting out measures to be applied without undue delay when the demand or the supply situation for critical SoHO present, or is likely to present, a serious risk to human health.

Critical SoHO entities should, without undue delay, send a SoHO supply alert to their SoHO competent authorities in the event of significant shortages of supply of critical SoHO, indicating the underlying reasons, the expected impact on recipients and any mitigating actions taken.

EU SoHO Platform

The Commission should establish, manage and maintain a digital platform to facilitate efficient and effective exchange of information concerning SoHO activities in the Union.

Documents
2024/02/14
   EP - Approval in committee of the text agreed at 1st reading interinstitutional negotiations
Documents
2024/01/30
   CSL - Coreper letter confirming interinstitutional agreement
2024/01/30
   EP - Text agreed during interinstitutional negotiations
Documents
2023/09/12
   EP - Results of vote in Parliament
2023/09/12
   EP - Decision by Parliament, 1st reading
Details

The European Parliament adopted by 483 votes to 82, with 59 abstentions, amendments to the proposal for a regulation of the European Parliament and of the Council on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC.

The matter was referred back to the committee responsible for inter-institutional negotiations.

Scope

The amended text establishes provisions on:

- exchange of information on availability and stocks of SoHOs, and promotion of actions relating to the security of SoHO supply;

- coordination between competent authorities and the Commission and Union agencies in the event of SoHO related health emergencies.

Members stipulated that this Regulation should not apply to breast milk that is expressed by a mother solely for the purpose of feeding her own child.

Voluntary and unpaid donation

Parliament stated that ‘ SoHO donation ’ means a process by which a person voluntarily and altruistically gives SoHOs from their own body to people in need, or authorises their use after their death. This includes the necessary medical formalities, examination and treatments and monitoring of the SoHO donor, irrespective of whether that donation is successful or not; it also includes when consent is given by an authorised person in accordance with national legislation.

Members stressed the fact that Member States may allow for the compensation or reimbursement from the SoHO entities to living SoHO donors for losses or expenses related to their participation in donations, in accordance with the principle of voluntary and unpaid donation, and for example taking the form of compensatory leave, tax reductions or flat rate allowances set at national level. Compensation or reimbursement should not serve as an incentive for donations or engender financial competition, including cross-border competition, between institutions and entities that are seeking donors. It should not lead to exploitation of vulnerable persons in society . Member States should regulate the advertising of the collection of SoHOs. Any advertising of SoHO donations linked to a financial reward should be prohibited. Recruitment campaigns and advertisements shall not refer to any compensation.

SoHO entities should provide the information in an accurate and clear manner, using terms that are easily understood by the prospective donors or the persons to consent or authorise the donation, and ensure that the consent given is informed consent .

Protection of recipients

SoHO entities should not discriminate against SoHO recipients on any of the grounds listed in Article 21 of the Charter of Fundamental Rights of the European Union, unless it is necessary to protect the health of the SoHO recipient or of the SoHO donor. Such discriminatory action shall be based on scientific evidence.

Where possible, SoHO entities should use technologies to reduce clinical risks for SoHO recipients and offspring from medically assisted reproduction, and to improve the quality of SoHOs.

Members introduced the possibility of a derogation from the obligation to authorise preparations based on substances of human origin in emergency situations or in situations where there is no therapeutic alternative.

Establishment of national emergency plans

In order to ensure EU self-sufficiency in SoHO supply, Member States should draw up national plans to strive for sufficiency of supply of critical SoHOs and contribute to European autonomy in the context of a resilient supply chain.

The national plans should in particular include measures to ensure that the donor base is resilient, actions to make a more efficient use of SoHOs, monitoring of trends in the supply of critical SoHOs as well as measures for cases where national SoHO stocks exceed the national demand and SoHOs are exported to other countries with SoHO shortages.

Members also called on the EU to establish a digital communication channel as part of these national plans, enabling information on the availability of substances of human origin on national territory to be exchanged quickly and efficiently.

EU strategy

By two years after the date of entry into force of this regulation, the Commission should publish a strategy for the promotion of European SoHO supply autonomy . That strategy should set out a roadmap with ambitious targets for each critical SoHO, laid down by the Commission in coordination with national competent authorities, the SCB, the ECDC, the European Parliament, scientists from professional associations and patient associations, as well as with all other relevant stakeholders.

The strategy should set out a roadmap with ambitious targets for each critical SoHO. It should promote actions to:

- support and coordinate communication campaigns at European and national level on the various types of SoHO donations that are available;

- support, through relevant programmes, the training of healthcare workers in hospital and healthcare facilities, to raise awareness concerning SoHO donations;

- coordinate the exchange of best practices linked to optimisation of the use of critical SoHOs.

The strategy should include actions to establish a Union list of critical SoHOs.

SoHO platform

To limit administrative burden on competent authorities and the Commission, the latter should establish an online platform (EU SoHO Platform) to facilitate timely submission of data and reports, to make it possible to share the elements used to determine the regulatory status of a substance, to improve the transparency of national reporting and supervisory activities and ensure better communication, collaboration and coordination in relation to, and exchange of, SoHOs between Member States.

The EU SoHO Platform should also be the main intermediary for reporting SoHO shortages, for cross-border requests for SoHOs and for import and export of SoHOs.

Documents
2023/09/12
   EP - Matter referred back to the committee responsible
2023/07/26
   EP - Committee report tabled for plenary, 1st reading
Details

The Committee on the Environment, Public Health and Food Safety adopted the report by Nathalie COLIN-OESTERLÉ (EPP, FR) on the proposal for a regulation of the European Parliament and of the Council on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC.

The committee responsible recommended that the European Parliament's position adopted at first reading under the ordinary legislative procedure should amend the proposal as follows:

Scope

The amended text establishes provisions on:

- exchange of information on availability and stocks of SoHOs, and promotion of actions relating to the security of SoHO supply;

- coordination between competent authorities and the Commission and Union agencies in the event of SoHO related health emergencies.

It should be noted that Members stipulated that this Regulation should not apply to breast milk that is expressed by a mother solely for the purpose of feeding her own child.

More stringent measures

Members stressed that the protection of donors and recipients should be ensured through the highest quality and safety standards. They suggested that the principle of voluntary and unpaid donation should be harmonised, in particular with a view to stopping differences in national rules from encouraging citizens to donate in other countries than their own for financial reasons.

Members insisted that EU countries should allow for compensation or reimbursement for losses or expenses, related to their participation in donations, to living donors. This could be facilitated through for example, compensatory leave, tax reductions or flat rate allowances set at the national level. They stressed that compensation should not be used as an incentive to recruit donors, nor lead to the exploitation of vulnerable people. The report also called on the EU to enforce strict rules on advertising around SoHO donations, which should prohibit any references to financial rewards. Moreover, recruitment campaigns and advertisements should not refer to any compensation.

The report also called for greater efforts to harmonise donation frequency rules between the Member States by giving the European Commission the power to adopt delegated acts on this specific matter.

Safeguarding supply

To ensure the autonomy of the EU’s supply of these substances, EU countries should establish national emergency and continuity of supply plans , which should include measures to ensure a resilient donor base, monitoring of the supply of critical SoHOs and proposals to improve cooperation between countries with excess stocks and those experiencing shortages. Members also called for the EU to establish a digital communication channel as part of these national plans, to store and analyse information on SoHOs availability, fluctuations and potential shortages.

EU strategy

Members called for the development of a strategy for the promotion of European SoHO supply autonomy. The strategy should set out a roadmap with ambitious targets for each critical SoHO. It should promote actions to:

- support and coordinate communication campaigns at European and national level on the various types of SoHO donations that are available;

- support, through relevant programmes, the training of healthcare workers in hospital and healthcare facilities, to raise awareness concerning SoHO donations;

- coordinate the exchange of best practices linked to optimisation of the use of critical SoHOs.

The strategy should include actions to establish a Union list of critical SoHOs .

SoHO platform

To limit administrative burden on competent authorities and the Commission, the latter should establish an online platform (EU SoHO Platform) to facilitate timely submission of data and reports, to make it possible to share the elements used to determine the regulatory status of a substance, to improve the transparency of national reporting and supervisory activities and ensure better communication, collaboration and coordination in relation to, and exchange of, SoHOs between Member States.

In order to prevent supply tensions and to ensure donor and recipient security, the Commission should ensure that the EU SoHO Platform is interoperable with the other existing Union platforms, in particular the EMA’s European Shortages Monitoring Platform. The EU SoHO Platform should also be the main intermediary for reporting SoHO shortages, for cross-border requests for SoHOs and for import and export of SoHOs.

Documents
2023/07/18
   EP - Vote in committee, 1st reading
2023/03/14
   EP - Amendments tabled in committee
Documents
2023/03/14
   EP - Amendments tabled in committee
Documents
2023/03/14
   EP - Amendments tabled in committee
Documents
2023/01/18
   EP - Committee draft report
Documents
2022/12/21
   PT_PARLIAMENT - Contribution
Documents
2022/10/26
   ESC - Economic and Social Committee: opinion, report
Documents
2022/10/20
   EP - COLIN-OESTERLÉ Nathalie (EPP) appointed as rapporteur in ENVI
2022/10/14
   CZ_CHAMBER - Contribution
Documents
2022/10/10
   ES_PARLIAMENT - Contribution
Documents
2022/09/12
   EP - Committee referral announced in Parliament, 1st reading
2022/09/07
   EDPS - Document attached to the procedure
2022/07/14
   EC - Document attached to the procedure
2022/07/14
   EC - Document attached to the procedure
2022/07/14
   EC - Document attached to the procedure
Documents
2022/07/14
   EC - Document attached to the procedure
2022/07/14
   EC - Legislative proposal published
Details

PURPOSE: to ensure a high level of health protection for EU citizens and ensure access to safe and effective substances of human origin (blood, tissue and cells) (SoHOs).

PROPOSED ACT: Regulation of the European Parliament and of the Council.

ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

BACKGROUND: every year, EU patients are treated with 25 million blood transfusions (during emergency surgery, cancer or other care), a million cycles of medically assisted reproduction, over 35 000 transplants of stem cells (mainly for blood cancers) and hundreds of thousands of replacement tissues (e.g., for orthopaedic, skin, cardiac or eye problems).

The EU framework for safety and quality of substances of human origin (SoHOs) has currently three main Directives, respectively for Blood, Tissues and Cells, and Organs , together with implementing legislation.

Although these Directives have harmonised to a certain degree the rules of Member States in the area of safety and quality of blood, tissues and cells, they include a significant number of options and possibilities for Member States to implement the rules they laid down. This results in divergences between national rules , which can create obstacles to cross-border sharing of these substances.

A fundamental revision of those Directives is needed for a robust, transparent, up-to-date and sustainable regulatory framework for these substances, which achieves safety and quality for all parties involved, enhances legal certainty and supports continuous supply, whilst facilitating innovation for the benefit of public health. In addition, the proposal aims to tackle concerns regarding the sufficiency of supply highlighted by the COVID-19 pandemic.

This initiative is part of the EU’s ambition to build a stronger European Health Union.

CONTENT: the proposed Regulation aims to establish measures setting high standards of quality and safety for all substances of human origin intended for human applications and for activities related to these substances, in order to ensure a high level of human health protection, in particular for donors of substances of human origin, recipients of substances of human origin and offspring of medically assisted reproduction.

All substances of human origin would be covered, with the exception of solid organs. Human breast milk is one of the new substances covered by the proposal.

More specifically, the proposal provides for measures to:

- ensure safety and quality for patients receiving SoHO therapies and fully protect them from avoidable risks related to substances of human origin;

- ensure safety and quality for donors of substances of human origin and for children born from donated eggs, sperm or embryos;

- empower the EU and its Member States to better prevent and combat future pandemics (surveillance, data analysis, risk assessment, early warning and rapid response);

- facilitate the development of innovative, safe and effective SoHO therapies ;

- improve the resilience of European health systems (sufficient supply of human-derived substances) by mitigating the risk of shortages.

Specifically, the proposal:

- improves the protection of patients treated with SoHO (recipients) and offspring from medically assisted reproduction, with standards, and how to implement these standards concerning recipient and offspring protection;

- contains provisions on the competent authorities for substances of human origin, which are responsible for the supervisory activities;

- covers all activities that competent authorities undertake in relation to SoHO entities or registration procedures, with the obligation to maintain a register of SoHO entities and to establish a procedure for their registration ;

- describes all general obligations on SoHO entities, namely their registration, the nomination of a Responsible Person if they release substances of human origin for clinical use, as well as obligations regarding the export of SoHOs;

- requires blood and tissue establishments to meet safety and quality standards by following guidelines developed and updated by designated expert bodies such as the European Centre for Disease Prevention and Control (ECDC) and the European Directorate for the Quality of Medicines and Health Care (Council of Europe);

- lays down provisions to ensure the continuity of supply of SoHOs . It covers the obligation for Member States to have national SoHO emergency plans (for SoHOs that are critically important for patients) and the responsibilities of competent authorities and entities regarding supply alerts for critical SoHOs.

A SoHO Coordination Board (SCB) would be established with and for the Member States to support a common implementation of the new Regulation.

The creation of the EU SoHO Platform , to gather all required information, streamline reporting and increase visibility to citizens will give a new impetus to digitalisation.

BUDGETARY IMPLICATIONS: the financial impact of the proposal is estimated at EUR 55.411 million in commitment appropriations for the period 2024-2027. The appropriations will be reallocated within the financial envelope of the EU Health Programme in the Multiannual Financial Framework (MFF) 2021-2027.

Documents

  • Draft final act: 00008/2024/LEX
  • Decision by Parliament, 1st reading: T9-0353/2024
  • Approval in committee of the text agreed at 1st reading interinstitutional negotiations: PE758.999
  • Coreper letter confirming interinstitutional agreement: GEDA/A/(2024)000898
  • Text agreed during interinstitutional negotiations: PE758.999
  • Results of vote in Parliament: Results of vote in Parliament
  • Decision by Parliament, 1st reading: T9-0299/2023
  • Committee report tabled for plenary, 1st reading: A9-0250/2023
  • Amendments tabled in committee: PE740.835
  • Amendments tabled in committee: PE745.276
  • Amendments tabled in committee: PE745.277
  • Committee draft report: PE738.661
  • Contribution: COM(2022)0338
  • Economic and Social Committee: opinion, report: CES4815/2022
  • Contribution: COM(2022)0338
  • Contribution: COM(2022)0338
  • Document attached to the procedure: OJ C 450 28.11.2022, p. 0007
  • Document attached to the procedure: N9-0084/2022
  • Document attached to the procedure: EUR-Lex
  • Document attached to the procedure: SEC(2022)0304
  • Document attached to the procedure: EUR-Lex
  • Document attached to the procedure: SWD(2022)0189
  • Document attached to the procedure: SWD(2022)0190
  • Document attached to the procedure: EUR-Lex
  • Document attached to the procedure: SWD(2022)0191
  • Legislative proposal published: COM(2022)0338
  • Legislative proposal published: EUR-Lex
  • Document attached to the procedure: EUR-Lex SEC(2022)0304
  • Document attached to the procedure: EUR-Lex SWD(2022)0189
  • Document attached to the procedure: SWD(2022)0190
  • Document attached to the procedure: EUR-Lex SWD(2022)0191
  • Document attached to the procedure: OJ C 450 28.11.2022, p. 0007 N9-0084/2022
  • Economic and Social Committee: opinion, report: CES4815/2022
  • Committee draft report: PE738.661
  • Amendments tabled in committee: PE740.835
  • Amendments tabled in committee: PE745.276
  • Amendments tabled in committee: PE745.277
  • Coreper letter confirming interinstitutional agreement: GEDA/A/(2024)000898
  • Text agreed during interinstitutional negotiations: PE758.999
  • Draft final act: 00008/2024/LEX
  • Contribution: COM(2022)0338
  • Contribution: COM(2022)0338
  • Contribution: COM(2022)0338

Votes

Normes de qualité et de sécurité des substances d’origine humaine destinées à une application humaine - A9-0250/2023 - Nathalie Colin-Oesterlé - Amendements de la commission compétente - vote en bloc - Am 59 #

2023/09/12 Outcome: +: 380, -: 228, 0: 13
ES FR SE PT BE FI DK NL CZ DE BG LU RO IE LV CY EE LT HR SI MT SK EL HU AT PL IT
Total
53
74
20
19
19
11
13
26
19
85
14
5
29
13
7
6
5
11
12
8
5
9
19
15
17
44
63
icon: S&D S&D
123

Belgium S&D

1

Finland S&D

1

Denmark S&D

2

Czechia S&D

For (1)

1

Luxembourg S&D

For (1)

1

Latvia S&D

2

Cyprus S&D

2

Estonia S&D

2

Lithuania S&D

2

Slovenia S&D

2
4

Greece S&D

1
icon: Renew Renew
92
3

Finland Renew

3

Bulgaria Renew

2

Luxembourg Renew

2

Ireland Renew

2

Latvia Renew

For (1)

1

Estonia Renew

For (1)

1

Lithuania Renew

1

Croatia Renew

For (1)

1

Slovenia Renew

2

Slovakia Renew

2

Greece Renew

1

Hungary Renew

2

Poland Renew

1
icon: Verts/ALE Verts/ALE
66

Sweden Verts/ALE

3

Portugal Verts/ALE

1

Belgium Verts/ALE

Abstain (1)

3

Finland Verts/ALE

2

Denmark Verts/ALE

Against (1)

2

Netherlands Verts/ALE

3

Czechia Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Romania Verts/ALE

1

Ireland Verts/ALE

2

Lithuania Verts/ALE

2

Austria Verts/ALE

3

Poland Verts/ALE

For (1)

1

Italy Verts/ALE

3
icon: The Left The Left
33

Sweden The Left

For (1)

1

Portugal The Left

2

Belgium The Left

For (1)

1

Finland The Left

For (1)

1

Denmark The Left

1

Netherlands The Left

For (1)

1

Czechia The Left

1

Cyprus The Left

2
icon: NI NI
36

France NI

Against (2)

Abstain (1)

3

Belgium NI

For (1)

1

Netherlands NI

2

Germany NI

Against (1)

3

Latvia NI

1

Lithuania NI

Abstain (1)

1

Croatia NI

Against (1)

Abstain (1)

2
icon: ECR ECR
55

Sweden ECR

3

Finland ECR

Against (1)

1

Bulgaria ECR

Against (1)

1

Romania ECR

1

Latvia ECR

Abstain (1)

1

Lithuania ECR

Against (1)

1

Croatia ECR

Against (1)

1

Slovakia ECR

Against (1)

1

Greece ECR

Against (1)

1
icon: ID ID
57

Denmark ID

Against (1)

1

Czechia ID

For (1)

1

Estonia ID

Against (1)

1

Austria ID

3
icon: PPE PPE
159

Belgium PPE

Against (1)

3

Denmark PPE

For (1)

1

Netherlands PPE

4

Luxembourg PPE

1

Latvia PPE

2

Cyprus PPE

2

Estonia PPE

Against (1)

1

Croatia PPE

Abstain (1)

4

Slovenia PPE

4

Malta PPE

Against (1)

1

Hungary PPE

Against (1)

1

A9-0250/2023 - Nathalie Colin-Oesterlé - Amendements de la commission compétente - vote en bloc - Am 85 #

2023/09/12 Outcome: +: 517, -: 86, 0: 23
FR DE IT PL ES PT RO EL AT SE HR BG NL IE BE LT SI CY FI LV MT SK LU EE CZ DK HU
Total
74
85
65
45
53
21
30
18
17
20
12
13
26
13
19
10
8
6
11
7
5
9
5
6
19
13
16
icon: PPE PPE
155

Cyprus PPE

2

Finland PPE

2

Latvia PPE

2

Malta PPE

For (1)

1

Slovakia PPE

Abstain (1)

4

Luxembourg PPE

1

Estonia PPE

For (1)

1

Denmark PPE

Against (1)

1

Hungary PPE

Against (1)

1
icon: S&D S&D
128

Greece S&D

1

Belgium S&D

1

Lithuania S&D

2

Slovenia S&D

2

Cyprus S&D

2

Finland S&D

1

Latvia S&D

2

Luxembourg S&D

For (1)

1

Estonia S&D

2

Czechia S&D

For (1)

1

Denmark S&D

2
icon: Verts/ALE Verts/ALE
66

Italy Verts/ALE

3

Poland Verts/ALE

For (1)

1

Portugal Verts/ALE

1

Romania Verts/ALE

1

Austria Verts/ALE

3

Sweden Verts/ALE

3

Netherlands Verts/ALE

3

Ireland Verts/ALE

2

Belgium Verts/ALE

3

Lithuania Verts/ALE

2

Finland Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Czechia Verts/ALE

2

Denmark Verts/ALE

2
icon: ECR ECR
56

Romania ECR

1

Sweden ECR

For (1)

3

Croatia ECR

1

Bulgaria ECR

1

Netherlands ECR

Against (2)

Abstain (1)

5

Lithuania ECR

1

Latvia ECR

For (1)

1

Slovakia ECR

Against (1)

1
icon: ID ID
57

Austria ID

3

Estonia ID

Abstain (1)

1

Czechia ID

For (1)

1

Denmark ID

Against (1)

1
icon: The Left The Left
35

Sweden The Left

For (1)

1

Netherlands The Left

For (1)

1

Belgium The Left

For (1)

1

Cyprus The Left

2

Finland The Left

For (1)

1

Czechia The Left

Against (1)

1

Denmark The Left

1
icon: NI NI
36

Croatia NI

Abstain (1)

2

Netherlands NI

For (1)

Against (1)

2

Belgium NI

For (1)

1

Lithuania NI

1

Latvia NI

1
icon: Renew Renew
93

Italy Renew

3

Poland Renew

1

Greece Renew

Against (1)

1

Sweden Renew

3

Croatia Renew

For (1)

1

Bulgaria Renew

2

Ireland Renew

2

Lithuania Renew

Against (1)

1

Slovenia Renew

For (1)

Against (1)

2

Finland Renew

3

Latvia Renew

Against (1)

1

Slovakia Renew

For (1)

Against (1)

2

Luxembourg Renew

For (1)

Against (1)

2

Estonia Renew

Against (2)

2

Hungary Renew

2

A9-0250/2023 - Nathalie Colin-Oesterlé - Proposition de la Commission #

2023/09/12 Outcome: +: 483, 0: 89, -: 52
DE ES IT FR RO PL PT NL SE BE DK EL BG AT IE FI LT CZ SI CY HU LV HR LU SK EE MT
Total
85
51
65
73
30
45
21
26
20
19
13
19
14
17
13
12
11
19
8
6
16
6
10
5
9
6
5
icon: PPE PPE
155

Denmark PPE

For (1)

1

Slovenia PPE

Abstain (1)

4

Cyprus PPE

2

Hungary PPE

Against (1)

1

Latvia PPE

2

Croatia PPE

For (1)

Abstain (1)

2

Luxembourg PPE

1

Slovakia PPE

4

Estonia PPE

For (1)

1

Malta PPE

Against (1)

1
icon: S&D S&D
126

Belgium S&D

1

Denmark S&D

2

Greece S&D

1

Finland S&D

1

Lithuania S&D

2

Czechia S&D

For (1)

1

Slovenia S&D

2

Cyprus S&D

2

Latvia S&D

2

Luxembourg S&D

For (1)

1

Estonia S&D

2
icon: Renew Renew
92

Poland Renew

1
3

Greece Renew

1

Bulgaria Renew

2

Ireland Renew

2

Finland Renew

3

Lithuania Renew

1

Slovenia Renew

2

Hungary Renew

2

Croatia Renew

For (1)

1

Luxembourg Renew

2

Slovakia Renew

2

Estonia Renew

2
icon: Verts/ALE Verts/ALE
66

Italy Verts/ALE

3

Romania Verts/ALE

1

Poland Verts/ALE

For (1)

1

Portugal Verts/ALE

1

Netherlands Verts/ALE

3

Sweden Verts/ALE

3

Belgium Verts/ALE

3

Denmark Verts/ALE

2

Austria Verts/ALE

3

Ireland Verts/ALE

2

Finland Verts/ALE

2

Lithuania Verts/ALE

2

Czechia Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1
icon: The Left The Left
35

Netherlands The Left

For (1)

1

Sweden The Left

For (1)

1

Belgium The Left

For (1)

1

Denmark The Left

1

Ireland The Left

Against (1)

4

Finland The Left

For (1)

1

Czechia The Left

1

Cyprus The Left

2
icon: NI NI
36

Germany NI

Abstain (1)

3

France NI

3

Netherlands NI

For (1)

Against (1)

2

Belgium NI

For (1)

1

Lithuania NI

Abstain (1)

1

Latvia NI

1

Croatia NI

2
icon: ECR ECR
57

Romania ECR

Abstain (1)

1

Netherlands ECR

Abstain (1)

5

Sweden ECR

3

Greece ECR

Abstain (1)

1

Bulgaria ECR

Abstain (1)

1

Finland ECR

2

Lithuania ECR

Abstain (1)

1

Latvia ECR

Abstain (1)

1

Croatia ECR

Against (1)

1

Slovakia ECR

Abstain (1)

1
icon: ID ID
57

Denmark ID

For (1)

1

Austria ID

3

Czechia ID

Against (1)

1

Estonia ID

Against (1)

1

A9-0250/2023 – Nathalie Colin-Oesterlé – Provisional agreement – Am 244 #

2024/04/24 Outcome: +: 461, 0: 66, -: 56
DE ES FR IT PL RO NL SE PT BE AT IE FI CZ DK BG LT EL EE LV SI LU HU HR MT SK
Total
84
53
74
47
43
21
27
20
16
21
17
12
13
21
11
13
10
13
7
7
7
6
15
11
4
10
icon: PPE PPE
146
3

Denmark PPE

For (1)

1

Estonia PPE

For (1)

1

Slovenia PPE

Abstain (1)

3

Luxembourg PPE

2

Hungary PPE

Abstain (1)

1

Croatia PPE

Abstain (1)

3

Malta PPE

For (1)

1

Slovakia PPE

4
icon: S&D S&D
114

Romania S&D

2

Belgium S&D

2

Czechia S&D

For (1)

1

Denmark S&D

2

Bulgaria S&D

2

Lithuania S&D

2

Greece S&D

1

Estonia S&D

2

Latvia S&D

2

Slovenia S&D

2

Luxembourg S&D

For (1)

1

Slovakia S&D

For (1)

1
icon: Renew Renew
94

Poland Renew

1
3

Austria Renew

For (1)

1

Ireland Renew

2

Finland Renew

3

Bulgaria Renew

2

Lithuania Renew

1

Greece Renew

1

Estonia Renew

3

Latvia Renew

For (1)

1

Slovenia Renew

2

Luxembourg Renew

2

Hungary Renew

For (1)

1

Croatia Renew

For (1)

1
icon: Verts/ALE Verts/ALE
66

Spain Verts/ALE

3

Italy Verts/ALE

2

Poland Verts/ALE

For (1)

1

Netherlands Verts/ALE

3

Sweden Verts/ALE

3

Portugal Verts/ALE

1

Belgium Verts/ALE

3

Austria Verts/ALE

3

Ireland Verts/ALE

2

Finland Verts/ALE

3

Czechia Verts/ALE

Abstain (1)

3

Denmark Verts/ALE

For (1)

1

Lithuania Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1
icon: The Left The Left
30

Belgium The Left

For (1)

1

Finland The Left

For (1)

1

Czechia The Left

1

Denmark The Left

1

Greece The Left

2
icon: NI NI
32

Germany NI

Abstain (1)

2

Spain NI

1

France NI

Against (1)

3

Romania NI

For (1)

1

Netherlands NI

Against (1)

1

Belgium NI

For (1)

1

Czechia NI

Against (1)

1

Greece NI

For (1)

Against (1)

3

Latvia NI

1

Croatia NI

Against (1)

Abstain (1)

2

Slovakia NI

Against (1)

1
icon: ECR ECR
55

Germany ECR

Abstain (1)

1

France ECR

Against (1)

1

Romania ECR

Abstain (1)

1

Netherlands ECR

4

Sweden ECR

3

Finland ECR

1

Czechia ECR

Against (1)

Abstain (1)

4

Bulgaria ECR

2

Lithuania ECR

Abstain (1)

1

Greece ECR

Against (1)

1

Croatia ECR

Against (1)

1

Slovakia ECR

Abstain (1)

1
icon: ID ID
46

Austria ID

Against (2)

2

Czechia ID

Abstain (1)

1

Denmark ID

For (1)

1

Estonia ID

For (1)

1
AmendmentsDossier
757 2022/0216(COD)
2023/03/14 ENVI 757 amendments...